Summary
Samenvatting Theorie kine bij ouderen
- Course
- Institution
Dit is een samenvatting van alle theorie lessen kine bij ouderen, gevolgd in het jaar .
[Show more]
Seller
Follow
qcgr2324
Content preview
KINE BIJ OUDEREN THEORIE,Healty aging (hoorcollege 1) ............................................................................................................................................................... 9
inleiding........................................................................................................................................................................................... 9
er is behoefte aan vertaling van wetenschappelijk onderzoek naar de praktijk ........................................................................ 9
Geriatrische fysiotherapie: noodzaak van juiste perceptie! ....................................................................................................... 9
case study ................................................................................................................................................................................... 9
wat is evidence based medicine? ................................................................................................................................................. 10
methodisch handelen ............................................................................................................................................................... 10
effectieve besluitvorming over behandeling vereist oordelijkundig klinisch redeneren .......................................................... 10
Klinisch redeneren is een denkproces om de PT tot 'verstandige' actie aan te zetten ............................................................ 10
Diagnose ....................................................................................................................................................................................... 11
gezond ouder worden ................................................................................................................................................................... 12
volgens de WHO omvat dit: ...................................................................................................................................................... 12
vroegtijdig ingrijpen ...................................................................................................................................................................... 13
WHO icope screening mechanisme .............................................................................................................................................. 13
doelen van de geriatrische fysiotherapeut zijn gerelateerd aan functie, activiteit & onafhankelijkheid ..................................... 14
medisch model .............................................................................................................................................................................. 15
synergetic morbidity model ...................................................................................................................................................... 15
attribution model ...................................................................................................................................................................... 15
causal chain model.................................................................................................................................................................... 15
unmasking event model ............................................................................................................................................................ 15
polyfarmacie ............................................................................................................................................................................. 16
kwetsbaarheid (hoorcollege 1) ......................................................................................................................................................... 16
frailty ......................................................................................................................................................................................... 17
er zijn verschillende modellen van frailty ................................................................................................................................. 17
FRIED model (fenotype model) ........................................................................................................................... 17
cumulatieve deficiet model (= Rockwood).......................................................................................................... 18
veerkracht ..................................................................................................................................................................................... 20
veerkracht en kwetsbaarheid worden negatief geassocieerd .................................................................................................. 20
vergelijking van kwetsbaarheid en veerkracht ......................................................................................................................... 20
interventies voor kwetsbaarheid .................................................................................................................................................. 21
slaapdisfunctie, diabetes en decubitus (hoorcollege 2) ................................................................................................................... 22
1
, slaap bij ouderen........................................................................................................................................................................... 22
slaappatroon ............................................................................................................................................................................. 22
aandoeningen van de slaap ...................................................................................................................................................... 24
slaapapneu .......................................................................................................................................................... 24
periodieke beenbewegingen ............................................................................................................................... 25
vervroegde slaapfase syndroom ......................................................................................................................... 25
Rem slaap gedragsstoornis.................................................................................................................................. 25
medische aandoeningen ..................................................................................................................................... 26
psychiatrische aandoeningen .............................................................................................................................. 26
organische hersensyndroom ............................................................................................................................... 26
Onderzoek ................................................................................................................................................................................. 26
behandeling .............................................................................................................................................................................. 27
diabetes ........................................................................................................................................................................................ 27
chronische verwikkelingen........................................................................................................................................................ 28
occulair = visusstoornissen.................................................................................................................................. 28
neurologisch ........................................................................................................................................................ 28
macrovasculair .................................................................................................................................................... 28
microvasculair ..................................................................................................................................................... 29
osteoarticulair ..................................................................................................................................................... 29
therapeutishe benadering ........................................................................................................................................................ 29
vasculaire pathologie .................................................................................................................................................................... 29
veneuze insufficiëntie ............................................................................................................................................................... 29
arteriële insufficientie: perifeer ................................................................................................................................................ 30
decubitus (doorligwonden) ........................................................................................................................................................... 31
psychogeriatrie (hoorcollege 3) ........................................................................................................................................................ 35
normale veroudering-cognitieve en gedragsmatige veranderingen ............................................................................................ 35
dementie ....................................................................................................................................................................................... 36
klinische kenmerken ................................................................................................................................................................. 38
verschillende vormen van dementie......................................................................................................................................... 39
ziekte van alzheimer ........................................................................................................................................... 40
lewy body dementie............................................................................................................................................ 41
ziekte van parkinson ........................................................................................................................................... 41
vasculaire dementie ............................................................................................................................................ 42
frontotemporale dementie ................................................................................................................................. 43
2
, risicofactoren dementie ............................................................................................................................................................ 43
verloop volgens etiologie .......................................................................................................................................................... 43
corticale en subcorticale vormen van dementie....................................................................................................................... 44
stadia van dementie.................................................................................................................................................................. 44
differentiaal diagnose dementie ............................................................................................................................................... 46
mild cognitive impairment (MCI) = geeft geen probleem in het dagelijkse leven .............................................. 46
delirium = plotseling optreden van ernstige verwardheid die een lichamelijke oorzaak heeft .......................... 46
depressie bij ouderen ............................................................................................................................................................... 48
motoriek en dementie .............................................................................................................................................................. 49
pijn en dementie ....................................................................................................................................................................... 49
behandeling .............................................................................................................................................................................. 50
omgaan met personen met dementie ...................................................................................................................................... 52
sarcopenie-fysieke activiteit (hoorcollege 4) .................................................................................................................................... 52
active aging ................................................................................................................................................................................... 52
sarcopenie: fysieke kwetsbaarheid ........................................................................................................................................... 54
de belgische vereniging voor gerontologie en geriatrie ontwikkelde een richtlijn sarcopenie ................................................ 55
spierkracht .......................................................................................................................................................... 56
fysieke performance............................................................................................................................................ 57
exercise................................................................................................................................................................ 58
farmacologie (minder belangrijk)........................................................................................................................ 61
Farmacotherapie en revaki bij ouderen (Hoorcollege 5) .................................................................................................................. 62
aandoeningen & medicatie: artrose ............................................................................................................................................. 64
paracetamol .............................................................................................................................................................................. 64
paracetamol & revaki ................................................................................................................................................................ 64
niet-narcotische analgetica (NSAID) ......................................................................................................................................... 64
NSAID en revaki......................................................................................................................................................................... 64
aandoeningen & medicatie: beroerte ........................................................................................................................................... 65
medicatie ter secundaire preventie van atherosclerose A. carotis .......................................................................................... 65
beroerte medicatie & revaki ..................................................................................................................................................... 65
aandoeningen & medicatie: osteoporose ..................................................................................................................................... 65
botontkalking kan ontstaan door de menopauze en/of medicatiegebruik .............................................................................. 65
botontkalking wordt vermeden en behandeld met beweging en medicatie ........................................................................... 65
3
, osteoporose medicatie en revaki.............................................................................................................................................. 65
aandoeningen & medicatie: cataract & glaucoom ....................................................................................................................... 66
cataract en glaucoom zijn verschillende oogaandoeningen ..................................................................................................... 66
glaucoom medicatie en revaki .................................................................................................................................................. 66
aandoeningen & medicatie: herpes zoster ................................................................................................................................... 66
bij ouderen neemt de immunologische afeer tegen varicellazostervirus af............................................................................. 66
postherpeszosterinfectie .......................................................................................................................................................... 66
herpes zoster medicatie & revaki ............................................................................................................................................. 67
aandoeningen & medicatie: prostaathyperplasie ......................................................................................................................... 67
postaathyperplasie komt veel voor bij oudere mannen ........................................................................................................... 67
prostaathyperplasie medicatie & revaki ................................................................................................................................... 67
aandoeningen & medicatie: urine-incontinentie .......................................................................................................................... 67
urine-incontinentie komt vaker voor bij oudere vrouwen dan bij mannen ............................................................................. 67
urine-incontinentie medicatie & revaki .................................................................................................................................... 67
aandoeningen & medicatie: ziekte van parkinson ........................................................................................................................ 67
levodopa is het meest werkzame middel tegen symptomen van de ziekte van parkinson ..................................................... 67
ziekte van parkinson medicatie & revaki .................................................................................................................................. 68
aandoeningen en medicatie: pijn (acute pijn → medicatie voorgeschreven) .............................................................................. 68
de who pijnladder werd opgesteld met het oog op pijnstelling bij acute pijn ......................................................................... 68
codeïne (wordt veel minder gebruikt) is nauw verwant aan morfine ...................................................................................... 68
de pijnstillende werking van tramadol is ongeveer even sterk als codeïne ............................................................................. 68
er bestaan verschillende soorten opoïden ............................................................................................................................... 68
pijn medicatie & revaki ............................................................................................................................................................. 68
Overzicht bijwerkingen ................................................................................................................................................................. 69
artrose en oefenen (hoorcollege 6) .................................................................................................................................................. 70
osteoarthritis (OA) ........................................................................................................................................................................ 70
epidemiologie ........................................................................................................................................................................... 70
definitie knie osteoartritis ......................................................................................................................................................... 70
pathologie – kraakbeen ............................................................................................................................................................ 71
Oa-gerelateerde weefselafwijkingen (remodellering) .............................................................................................................. 71
belangrijk! ................................................................................................................................................................................. 75
4
, mechanismen die het effeect van lichaamsbeweging verklaren .................................................................................................. 75
bewegen wordt aanbevolen door internationale richtlijnen .................................................................................................... 75
Geen specifieke aanbevelingen met betrekking tot de oefenmodaliteiten ............................................................................. 76
Bewegen heeft een matig effect op artrose kniepijn ............................................................................................................... 76
Patiënten onderverdelen in subgroepen is de basis van gepersonaliseerde gezondheidszorg ............................................... 76
Inzicht in de mechanismen die ten grondslag liggen aan de effecten van lichaamsbeweging kan helpen om behandelingen
te optimaliseren ........................................................................................................................................................................ 76
Belangrijk! ................................................................................................................................................................................. 77
behandeling van OA pijn ............................................................................................................................................................... 77
Een grote verschuiving in het begrijpen van artrosepijn... maar nog geen verschuiving in de huidige behandelingen voor OA-
pijn ............................................................................................................................................................................................ 77
Pijneducatie + Mulligan manuele therapie voor knieartrose ................................................................................................... 77
Gegradueerde activiteit = oefening aangepast aan de behoeften van de patiënt ................................................................... 77
houding (hoorcollege 7) .................................................................................................................................................................... 78
houding ......................................................................................................................................................................................... 78
anatomische en fysiologische veranderingen ........................................................................................................................... 78
gewrichtsstijfheid ...................................................................................................................................................................... 78
momentwerking heup .............................................................................................................................................................. 79
voornaamste veranderingen in houding ................................................................................................................................... 79
parkinson .................................................................................................................................................................................. 79
hyperkyfose................................................................................................................................................................................... 80
definitie en prevalentie ............................................................................................................................................................. 80
oorzaak en pathologie .............................................................................................................................................................. 80
geassocieerde gezondheidsrisico’s ........................................................................................................................................... 81
evaluatie.................................................................................................................................................................................... 81
observatie............................................................................................................................................................ 81
röntgen ................................................................................................................................................................ 82
cobb angle ........................................................................................................................................................... 82
debrunner kyphometer ....................................................................................................................................... 82
flexicurve ruler .................................................................................................................................................... 82
spinal mouse ....................................................................................................................................................... 82
inclinometer ........................................................................................................................................................ 82
occiput – to – wall ............................................................................................................................................... 83
5
, evaluatie .............................................................................................................................................................. 83
functionele testing .............................................................................................................................................. 83
behandeling .............................................................................................................................................................................. 83
manuele mobilisatie/mobilisaties ....................................................................................................................... 84
stretching ............................................................................................................................................................ 85
progressieve weerstandstraining ........................................................................................................................ 85
stabilisatietraining ............................................................................................................................................... 85
oefentherapie ...................................................................................................................................................... 85
proprioceptie/postural alignment....................................................................................................................... 86
postural taping .................................................................................................................................................... 86
spinale orthese “corset”...................................................................................................................................... 86
uithouding (hoorcollege 8) ............................................................................................................................................................... 86
deel 1: uithoudingsvermogen ....................................................................................................................................................... 86
centrale circulatie ..................................................................................................................................................................... 88
Hart ..................................................................................................................................................................... 88
Perifere circulatie ...................................................................................................................................................................... 89
Bloedvaten .......................................................................................................................................................... 89
Respiratoir systeem .................................................................................................................................................................. 89
Longfunctie ......................................................................................................................................................... 89
Spiermetabolisme ..................................................................................................................................................................... 90
Deel 2: Uithoudingsvermogen meten ........................................................................................................................................... 90
6 minuten wandeltest ............................................................................................................................................................... 90
2 minuten wandeltest ............................................................................................................................................................... 90
10m incremental schuttle walk test.......................................................................................................................................... 90
Åstrand-test .............................................................................................................................................................................. 91
Steep Ramp Test ....................................................................................................................................................................... 91
Deel3: Uithoudingsvermogen trainen ........................................................................................................................................... 91
Aerobe en anaerobe energiewinning ....................................................................................................................................... 91
GlYcolyse en oxidatieve fosforylering ....................................................................................................................................... 92
ATP-CP-systeem ........................................................................................................................................................................ 92
Oefenadviezen .......................................................................................................................................................................... 92
valpreventie (hoorcollege 9) ............................................................................................................................................................. 94
definitie van een valincident ......................................................................................................................................................... 94
6
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller qcgr2324. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $7.67. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
52355 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy study notes for 14 years now